OPPM
CLLS

Opus Point Partners Management’s Cellectis CLLS Stock Holding History

Opus Point Partners Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-22,309
Closed -$409K – 66
2019
Q1 		$409K Buy
+22,309
New +$395K 0.55% 45

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Opus Point Partners Management's CLLS Position: Q2 2019 in Review

Opus Point Partners Management sold out of Cellectis (CLLS) in Q2 2019, closing a stake of 22,309 shares — an estimated $409K sold.

Opus Point Partners Management first reported a position in CLLS in Q1 2019 and held it in 1 quarter. The position peaked at $409K in Q1 2019. 70 funds tracked by Wall St. Rank hold CLLS as of Q2 2019.

  • Opus Point Partners Management reported no remaining Cellectis position as of Q2 2019 after selling out during the quarter.
  • Opus Point Partners Management sold 22,309 Cellectis shares in Q2 2019, an estimated $409K.
  • Opus Point Partners Management first reported a position in Cellectis in Q1 2019 and held it in 1 quarter.
  • Opus Point Partners Management's Cellectis position peaked at $409K in Q1 2019.
  • 70 funds tracked by Wall St. Rank held Cellectis as of Q2 2019.

Based on Opus Point Partners Management's 13F filing for Q2 2019, filed 14 Aug 2019.